Myelodysplastic Syndromes (MDS)

Namrata Chandhok, MD

Institution
University of Miami Health System - Sylvester Comprehensive Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Dr. Chandhok, M.D. is a Hematologist and Oncologist at Sylvester Comprehensive Cancer Center. At Sylvester, Dr. Chandhok works as part of a multidisciplinary team treating patients with leukemia and myelodysplastic syndrome (myeloid malignancies) . She earned her medical degree from The George Washington University School of Medicine and Health Sciences, Washington DC. • Currently seeing patients with myeloid malignancies. • Avid participant in clinical trials. • Board certified in Internal Medicine and board eligible in Hematology and Oncology. • Completed her residency in Internal Medicine

Salil Goorha, MD

Institution
Baptist Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Salil Goorha joined the Baptist Medical Group team in 2018 and sees patients in Memphis, Tennessee.

Akshay Sharma, MBBS

Institution
St. Jude Children’s Research Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric

KER-050

KER-050: KER-050 is a therapeutic protein designed to increase red blood cell and platelet production by inhibiting the signaling of a subset of the transforming growth factor beta (TGF-ß) family of protei

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.